Search for: "Takeda California Inc"
Results 21 - 40
of 42
Sort by Relevance
|
Sort by Date
2 Jun 2013, 8:40 pm
Sandoz Inc. 3:13-cv-02418; filed May 29, 2013 in the Northern District of California • Plaintiffs: Takeda Pharmaceutical Co., Ltd.; Takeda Pharmaceuticals U.S.A., Inc.; Takeda Pharmaceuticals America, Inc. [read post]
2 May 2013, 9:55 am
Takeda Pharmaceuticals America, Inc., LASC No. [read post]
4 Mar 2013, 4:02 pm
Takeda Pharmaceuticals America Inc., CGC-12-518535, California Superior Court (Los Angeles) [read post]
23 Feb 2013, 11:37 am
Takeda Pharmaceuticals America, Inc., CGC-12-518535, California Superior Court (Los Angeles). [read post]
28 Dec 2012, 1:57 pm
Medtronic, Inc., 670 F.3d 569 (4th Cir. 2012). [read post]
5 Sep 2012, 3:30 pm
Among the complaints is a California dangerous drug case involving 12 plaintiffs who believe that the reason they developed bladder cancer was because they were taking Actos. [read post]
6 Aug 2012, 1:24 pm
This first lawsuit was filed in the San Francisco County Superior Court asserting that AstraZeneca Pharmaceuticals, Inc. and Takeda Pharmaceuticals USA, Inc. failed to conduct adequate and sufficient post-marketing surveillance of adverse events caused by ingestion of Nexium and Prevacid after they began marketing the drug. [read post]
1 Aug 2012, 11:17 am
Throughout the US, Altman & Altman, LLP represents clients with Actos lawsuits against manufacturer Takeda Pharmaceuticals America, Inc. [read post]
17 Feb 2012, 2:00 am
NetApp, Inc., where the issue was whether supplemental documents should be produced to comply with post-trial determination pursuant to DGCL Section 220 that books and records must be provided. 2) DealBook: Kodak Can Remove Name From Oscar Venue, Judge Rules – This post shares how lawyers for Eastman Kodak won bankruptcy court permission on Wednesday to cancel the company’s sponsorship agreement with the Los Angeles theater where the Oscars have been held for the last 10… [read post]
27 Jan 2012, 7:13 am
As a result, the FDA ordered the drug’s manufacturer, Takeda Pharmaceuticals North America, Inc., to update Actos symptoms on the drug’s label earlier this fall. [read post]
5 Jan 2012, 3:10 pm
In August, Plaintiffs with pending lawsuits against Japanese company Takeda Pharmaceuticals America Inc. [read post]
4 Jan 2012, 9:20 am
In August, Plaintiffs with pending lawsuits against Japanese company Takeda Pharmaceuticals America Inc. [read post]
18 Dec 2009, 9:59 am
(patent infringement) 12/2: Takeda Pharmaceutical Company Ltd. and Takeda Pharmaceutical North America Inc. v. [read post]
9 Dec 2009, 3:59 pm
Amgen Inc. [read post]
27 Sep 2009, 5:13 pm
Takeda Chemical Industries, Ltd., et al. [read post]
27 Mar 2009, 8:00 am
; no skulduggery involved in pharma enquiry submission switch says EPO (IPKat) (IAM) India: Public sector IP and socially responsible licensing (Spicy IP) India: Pharma lobby wants a probe into delayed orders (Spicy IP) UK: Euro costs in UK litigation: Actavis UK Ltd v Novartis AG (PatLit) US: Two biosimilars bills introduced in the House: HR 1427, the Promoting Innovation and Access to Life Saving Medicine Act; and H.R. 1548, the Pathway to BioSimilars Act (California Biotech Law Blog)… [read post]
14 Nov 2008, 2:08 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Plavix (Clopidogrel) - Canada: Selection patents upheld by Supreme Court: Apotex v Sanofi-Synthelabo Canada (Jeremy de Beer) (ipblog.ca) (Excess Copyright)… [read post]
13 Jun 2008, 3:40 am
’ – London: (IPKat), 18 June: CC technology summit – California: (creativecommons.org), 18-20 June: IIR generic drugs summit – Washington: (Orange Book Blog), 18-20 June / 9-11 July: US PLI: ‘Fundamentals of patent prosecution 2008: A boot camp for claim drafting & amendment writing’ – New York / San Francisco: (Patent Docs), 19-20 June: 27th ECTA Conference ‘Forty shades of green: a tour of the IP… [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
11 Apr 2008, 9:00 am
’ – 18 – 22 June, US/Alaska: (Public Knowledge), Center for IP 8th Annual IP Symposium – 28-30 May, Maryland US: (Public Knowledge), University of Maastricht: Conference on public health, innovation and intellectual property – 15 April, Maastricht (Netherlands): (IPR-Helpdesk), NLSIU Symposium: ‘Challenges to India’s patent regime’ – 12-13 April: (Spicy IP), Anti-counterfeiting and brand… [read post]
